12th Workshop, Barcelona: “Retooling the EU Orphan Drug Regulation and US Orphan Drug Act for Better and Faster Development of Rare Disease Therapies”

12th Workshop of the Eurordis Round Table of Companies:

“Retooling the EU Orphan Drug Regulation and US Orphan Drug Act for Better and Faster Development of Rare Disease Therapies”

 

June 18th, 2010

Barcelona, Spain

Peter Saltonstall, CEO of NORD with Yann Le Cam CEO of EURORDIS

A consensus was reached about using all the available tools offered by the current EU and US regulations, rather than starting a revision process for which the outcome would be rather uncertain. Several ways of improving the orphan drug regulations were evoked and solutions proposed to accelerate the development of orphan drugs on both sides of the Atlantic.

 

 

Participants: 61

Key feature: First time that a discussion bringing together all the stakeholders was taking place to reflect on the existing Orphan Drugs legislations both in the EU and US.

Programme

Concept Paper

Proceedings

For ERTC Members only, this document is password protected. If you want to become a member, find out more here or contact Anne-Mary Bodin, Operations Assistant.

 

 
 
A voz das pessoas com doenças raras na EuropaEURORDIS A voz internacional das pessoas com doenças raras, Rare Diseases InternacionalRare Disease International Reúne doentes, famílias e especialistas para partilhar experiências num fórum multilinguístico. RareConnect O programa Rare Barometer é uma iniciativa da EURORDIS para a realização de inquéritos para transformar a experiência das pessoas com doenças raras em números e factos que podem ser partilhados com os responsáveis pela tomada de decisões.Rare Barometer An international awareness raising campaign taking place on the last day of February each year, Rare Disease Day is a EURORDIS initiativeRare Disease Day Adira ao maior encontro europeu das partes interessadas no âmbito das doenças raras na Conferência Bienal Europeia sobre Doenças Raras e Produtos Órfãos. A ECRD é uma iniciativa da EURORDISEuropean Conference on Rare Diseases